GMALL Registry Study
- Gender
- Women and men
- Age
- 18–55 years
- Trial type
- Interventional
- Line of therapy
- Relapsed / refractory
- Phase
- Phase IV
What is this trial about?
The GMALL Registry Study is an observational study of adult patients with a specific type of blood cancer (acute lymphoblastic leukemia, ALL).
Detailed description
No specific therapy will be offered or tested as part of the study. ALL will therefore be treated with currently available medications, primarily following the so-called “GMALL protocol.” The goal of the study is to collect data on the disease and the medications used, for example, with a view to developing new medications. Patients who do not have classic ALL but rather conditions that are directly related to it may also participate.
Trial sites
14 trial sites in Germany are listed. Find a site near you.
Universitätsklinikum Augsburg
Stenglinstraße 2, 86156 Augsburg
Active, not recruitingCharité – Universitätsmedizin Berlin
Grosse Hamburger Strasse 5-11, 10115 Berlin
Active, not recruitingUniversitätsklinikum Bonn
Venusberg-Campus 1, 53127 Bonn
Active, not recruitingKlinikum Darmstadt GmbH
Darmstadt
ClosedUniversitätsklinikum Essen
Hufelandstraße 55, 45147 Essen
Active, not recruitingUniversitätsklinikum Frankfurt
60590 Frankfurt am Main
Closed
This list is compiled to the best of our knowledge but without guarantee: it may be incomplete, and a site's recruitment status can change at any time.
- Dr. med. Sebastian SommerSpecialist in internal medicine with a focus on hematology and oncology
- PD Dr. med. Matthias FröhlichSpecialist in internal medicine, immunology and emergency medicine
This description is based on the public trial registry (NCT02881086) and was translated into plain language by our medical editorial team. Whether participation is an option for you is a decision you make together with your treating physician.